Compare Tempus AI (TEM) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs UBS Group AG Registered Ordinary Shares — how do they compare? Tempus AI trades at $70.35 (market cap $12.77B), while UBS Group AG Registered Ordinary Shares trades at $47.72 (market cap $144.63B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 11.3× Tempus AI's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.32% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tempus AI for 22 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| TEM | UBS | |
|---|---|---|
Market Cap | $12.77B | $144.63B |
Volume | 8,980,490 | 1,746,723 |
Sector | Broad Market / Factor | Financials |
52-Week High | $99.28 | $55.72 |
52-Week Low | $41.55 | $36.41 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $13.40B | $311.50B |
Dividend Yield | — | 2.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
